Moderna, Inc. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Moderna, Inc. treasury stock, shares, acquired for the quarter ending 2023-12-31 was 0.00 shares.
- Moderna, Inc. treasury stock, shares, acquired for the quarter ending 2023-09-30 was 0.00 shares.
- Moderna, Inc. treasury stock, shares, acquired for the quarter ending 2023-06-30 was 4.00M shares.
- Moderna, Inc. treasury stock, shares, acquired for the quarter ending 2023-03-31 was 4.00M shares.
- Moderna, Inc. treasury stock, shares, acquired for fiscal 2025 was 0.00 shares.
- Moderna, Inc. treasury stock, shares, acquired for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- Moderna, Inc. treasury stock, shares, acquired for fiscal 2023 was 8.00M shares, a 65.22% decline from fiscal 2022.
- Moderna, Inc. treasury stock, shares, acquired for fiscal 2022 was 23.00M shares, a 666.67% increase from fiscal 2021.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-20 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-20 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | 8.00M shares 10-K · filed 2026-02-20 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | |
| 2023-06-30 | 4.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | |
| 2023-03-31 | 4.00M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 23.00M shares 10-K · filed 2025-02-21 | |
| 2021-12-31 | 3.00M shares 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |